12 research outputs found
Cell Mates
Catalog for the exhibition Cell Mates held at the Seton Hall University Walsh Gallery, June 3 - July 18, 2013. Curated by Jeanne Brasile and Lisbeth Murray. Includes the essays The Art of Science and the Science of Art by Jeanne Brasile and Incubating Hybrid Art by Lisbeth Murray. Includes color illustrations
Data In, Data Out
Catalog for the exhibition Data In, Data Out held at the Seton Hall University Walsh Gallery, October 31 - December 16, 2011. Curated by Jeanne Brasile. Includes an essay by Jeanne Brasile. Includes color illustrations
Crop Updates 2002 - Farming Systems
This session covers forty one papers from different authors:
INTRODUCTION
1. Future Farming Systems session for Crop Updates 2002 Peter Metcalf, FARMING SYSTEMS SUBPROGRAM MANAGER GRAINS PROGRAM Department of Agriculture
2. Perennial pastures in annual cropping systems: Lucerne and beyond, the ‘Big Picture’, Mike Ewing, Deputy CEO CRC for Plant-based Management of Dryland Salinity, Department of Agriculture
3. Perennial pastures in annual cropping systems: lucerne and beyond, Roy Latta and Keith Devenish, Department of Agriculture
4. Establishing Lucerne with a cover crop, Diana Fedorenko1, Clayton Butterly1, Chantelle Butterly1, Kim and Neil Diamond2, Stuart McAlpine2, Bill Bowden1, Jessica Johns3, 1Centre for Cropping Systems, Northam, 2Farmer, Buntine, 3Department of Agriculture
5. Overcropping: Chemical suppression of Lucerne, Terry Piper1, Diana Fedorenko1, Clayton Butterly1, Chantelle Butterly1, Stuart McAlpine2, Jessica Johns3, 1Centre for Cropping Systems, Northam, 2Farmer, Buntine, 3Department of Agriculture
6. Overcropping: Effect of Lucerne density on crop yield, Diana Fedorenko1, Bill Bowden1, Clayton Butterly1, Chantelle Butterly1, Stuart McAlpine2, Terry Piper1,1Centre for Cropping Systems, Department of Agriculture, Northam, 2Farmer, Buntine
7. Residual effect of weed management in the third year of Lucerne on the following wheat crop, Diana Fedorenko1, Clayton Butterly1, Chantelle Butterly1, Stuart McAlpine2,Terry Piper1, David Bowran1, Jessica Johns3,1Centre for Cropping Systems, Northam, 2Farmer, Buntine, 3Department of Agriculture
8. Production of Lucerne and serradella in four soil types, Diana Fedorenko1 Clayton Butterly1, Chantelle Butterly1, Robert Beard2 1Centre for Cropping Systems, Department of Agriculture, 2Farmer, Cunderdin
9. The effect of spray topping on newly established Lucerne, Keith Devenish, Agriculture Western Australia
10. Leakage from phase rotations involving Lucerne, Phil Ward, CSIRO Plant Industry
11. Fungal diseases present in Western Australian Lucerne crops, Dominie Wright and Nichole Burges, Department of Agriculture
12. Survey of Western Australian Lucerne stands reveals widespread virus infection, Roger Jones and Danae Harman, Crop Improvement Institute, Department of Agriculture, and Centre for Legumes in Mediterranean Agriculture, University of WA
ANNUAL PASTURE SYSTEMS
13. The use of Twist Fungus as a biosecurity measure against Annual Ryegrass Toxicity (ARGT), Greg Shea, GrainGuard Coordinator and George Yan, Biological and Resource Technology
14.Limitations and opportunities for increasing water use by annual crops and pastures, David Tennant1, Phil Ward2and David Hall1 1Department of Agriculture, 2CSIRO, Plant Industries, Floreat Park
15. Developing pasture species mixtures for more productive and sustainable cropping systems – 2001 crop performance, Anyou Liu, Clinton Revell and Candy Hudson, Centre for Cropping Systems, Department of Agriculture
16. Developing pasture species mixtures for more productive and sustainable cropping systems – weed management in regenerating mixtures, Anyou Liu and Clinton Revell, Centre for Cropping Systems, Department of Agriculture
17. Aphid tolerance of annual pasture legumes, Andrew Blake, Natalie Lauritsen, Department of Agriculture
18. Selecting the right variety for phase pasture systems, Keith Devenish, Department of Agriculture
19. Responses of alternative annual pasture and forage legumes to challenge with infectious subterranean clover mottle virus, John Fosu-Nyarko, Roger Jones, Lisa Smith, Mike Jones and Geoff Dwyer, State Agricultural Biotechnology Centre and Centre for Bioinformatics and Biological Computing, Murdoch University, Department of Agriculture, and Centre for Legumes in Mediterranean Agriculture
SOIL AND LAND MANAGEMENT
20. Nutrition in 2002: Decisions to be made as a result of last season, Bill Bowden,Western Australia Department of Agriculture
21. Profitability of deep banding lime, Michael O\u27Connell, Chris Gazey and David Gartner, Department of Agriculture
22. Lime efficiency percentage…the new measure of lime effectiveness for Western Australia, Amanda Miller, Department of Agriculture
23. Boron – should we be worried about it, Richard W. BellA, K. FrostA, Mike WongBand Ross BrennanC ASchool of Environmental Science, Murdoch University,
BCSIRO Land and Water, CDepartment of Agriculture
24. Impact of claying and other amelioration on paddock profit, N.J. Blake1, G. McConnell2, D. Patabendige1and N. Venn11Department of Agriculture, 2PlanFarm P/L
25. Raised bed farming in the 2001 growing season, Derk Bakker, Greg Hamilton, Dave Houlbrooke and Cliff Spann, Department of Agriculture
26. Economics of tramline farming systems, Paul Blackwell and Bindi Webb, Department of Agriculture, Stuart McAlpine, Liebe Group.
27. Relay planting from Tramlines to increase water use and productivity os summer crops, Dr Paul Blackwell, Department of Agriculture, Neil and Kim Diamond, Buntine. Liebe Group
28.Evidence-based zone management of paddock variability to improve profits and environmental outcomes, M.T.F. WongA, D. PatabendigeB, G. LyleA and K. WittwerA ACSIRO Land and Water, BDepartment of Agriculture
29. How much soil water is lost over summer in sandy soils? Perry Dolling1, Senthold Asseng2, Ian Fillery2, Phil Ward2and Michael Robertson3 1University of Western Australia/Department of Agriculture Western Australia/CSIRO, 2CSIRO Plant Industry 3CSIRO Sustainable Ecosystems, Indooroopilly, Queensland
FARMER DECISION SUPPORT AND ADOPTION
30. Economic comparisons of farming systems for the medium rainfall northern sandplain, No 1, Caroline Peek and David Rogers, Department of Agriculture
31. Sensitivity analysis of farming systems for the medium rainfall northern sandplain No 2, Caroline Peek and David Rogers, Department of Agriculture
32. Transition analysis of farming systems in the medium rainfall northern sandplain. No 3, Caroline Peek and David Rogers, Department of Agriculture
33. Implementing on-farm quality assurance, Peter Portmann, Manager Research and Development, The Grain Pool of Western Australia
34. On-farm research – principles of the ‘Test As You Grow’ kit, Jeff Russell, Department of Agriculture
35. Broadscale wheat variety comparisons featuring Wyalkatchem, Jeff Russell, Department of Agriculture
36. GrainGuardÔ - A biosecurity plan for the Canola Industry,Greg Shea Department of Agriculture
37. Are Western Australian broadacre farms efficient? Ben Henderson, University of Western Australia, Ross Kingwell, Department of Agriculture and University of Western Australia
DISEASE MODELLING WORKSHOP
38. WORKSHOP: Pest and disease forecasts for you! An interactive forum, Tresslyn Walmsley, Jean Galloway, Debbie Thackray, Moin Salam and Art Diggle, Centre for Legumes in Mediterranean Agriculture and Department of Agriculture
39. Blackspot spread: Disease models are based in reality (Workshop paper 1), JeanGalloway,Department of Agriculture
40. Blackspot spread: Scaling-up field data to simulate ‘Baker’s farm’ (Workshop paper 2), Moin U. Salam, Jean Galloway, Art J. Diggle and William J. MacLeod, Department of Agriculture, Western Australia
41. A decision support system for control of aphids and CMV in lupin crops (Workshop paper 3), Debbie Thackray, Jenny Hawkes and Roger Jones, Centre for Legumes in Mediterranean Agriculture and Department of Agricultur
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
Introduction:
The multiorgan impact of moderate to severe coronavirus infections in the post-acute phase is still poorly understood. We aimed to evaluate the excess burden of multiorgan abnormalities after hospitalisation with COVID-19, evaluate their determinants, and explore associations with patient-related outcome measures.
Methods:
In a prospective, UK-wide, multicentre MRI follow-up study (C-MORE), adults (aged ≥18 years) discharged from hospital following COVID-19 who were included in Tier 2 of the Post-hospitalisation COVID-19 study (PHOSP-COVID) and contemporary controls with no evidence of previous COVID-19 (SARS-CoV-2 nucleocapsid antibody negative) underwent multiorgan MRI (lungs, heart, brain, liver, and kidneys) with quantitative and qualitative assessment of images and clinical adjudication when relevant. Individuals with end-stage renal failure or contraindications to MRI were excluded. Participants also underwent detailed recording of symptoms, and physiological and biochemical tests. The primary outcome was the excess burden of multiorgan abnormalities (two or more organs) relative to controls, with further adjustments for potential confounders. The C-MORE study is ongoing and is registered with ClinicalTrials.gov, NCT04510025.
Findings:
Of 2710 participants in Tier 2 of PHOSP-COVID, 531 were recruited across 13 UK-wide C-MORE sites. After exclusions, 259 C-MORE patients (mean age 57 years [SD 12]; 158 [61%] male and 101 [39%] female) who were discharged from hospital with PCR-confirmed or clinically diagnosed COVID-19 between March 1, 2020, and Nov 1, 2021, and 52 non-COVID-19 controls from the community (mean age 49 years [SD 14]; 30 [58%] male and 22 [42%] female) were included in the analysis. Patients were assessed at a median of 5·0 months (IQR 4·2–6·3) after hospital discharge. Compared with non-COVID-19 controls, patients were older, living with more obesity, and had more comorbidities. Multiorgan abnormalities on MRI were more frequent in patients than in controls (157 [61%] of 259 vs 14 [27%] of 52; p<0·0001) and independently associated with COVID-19 status (odds ratio [OR] 2·9 [95% CI 1·5–5·8]; padjusted=0·0023) after adjusting for relevant confounders. Compared with controls, patients were more likely to have MRI evidence of lung abnormalities (p=0·0001; parenchymal abnormalities), brain abnormalities (p<0·0001; more white matter hyperintensities and regional brain volume reduction), and kidney abnormalities (p=0·014; lower medullary T1 and loss of corticomedullary differentiation), whereas cardiac and liver MRI abnormalities were similar between patients and controls. Patients with multiorgan abnormalities were older (difference in mean age 7 years [95% CI 4–10]; mean age of 59·8 years [SD 11·7] with multiorgan abnormalities vs mean age of 52·8 years [11·9] without multiorgan abnormalities; p<0·0001), more likely to have three or more comorbidities (OR 2·47 [1·32–4·82]; padjusted=0·0059), and more likely to have a more severe acute infection (acute CRP >5mg/L, OR 3·55 [1·23–11·88]; padjusted=0·025) than those without multiorgan abnormalities. Presence of lung MRI abnormalities was associated with a two-fold higher risk of chest tightness, and multiorgan MRI abnormalities were associated with severe and very severe persistent physical and mental health impairment (PHOSP-COVID symptom clusters) after hospitalisation.
Interpretation:
After hospitalisation for COVID-19, people are at risk of multiorgan abnormalities in the medium term. Our findings emphasise the need for proactive multidisciplinary care pathways, with the potential for imaging to guide surveillance frequency and therapeutic stratification
Global and local impacts of delayed mercury mitigation efforts
Mercury (Hg) is emitted to air by natural and anthropogenic sources, transports and deposits globally, and bioaccumulates to toxic levels in food webs. It is addressed under the global 2017 Minamata Convention, for which periodic effectiveness evaluation is required. Previous analyses have estimated the impact of different regulatory strategies for future mercury deposition. However, analyses using atmospheric models traditionally hold legacy emissions (recycling of previously deposited Hg) constant, and do not account for their possible future growth. Here, using an integrated modeling approach, we investigate how delays in implementing emissions reductions and the associated growing legacy reservoir affect deposition fluxes to ecosystems in different global regions. Assuming nearly constant yearly emissions relative to 2010, each 5-year delay in peak emissions defers by additional extra ca. 4 years the return to year 2010 global deposition. On a global average, each 5-year delay leads to a 14% decrease in policy impacts on local-scale Hg deposition. We also investigate the response of fish contamination in remote lakes to delayed action. We quantify the consequences of delay for limiting the Hg burden of future generations and show that traditional analyses of policy impacts provide best-case estimates
Mercury benefits of climate policy in China: Addressing the Paris Agreement and the Minamata Convention simultaneously
National commitments under the Paris Agreement on climate change interact with other global environmental objectives, such as those of the Minamata Convention on Mercury. We assess how mercury emissions and deposition reductions from national climate policy in China under the Paris Agreement could contribute to the country’s commitments under the Minamata Convention. We examine emissions under climate policy scenarios developed using a computable general equilibrium model of China’s economy, end-of-pipe control scenarios that meet China’s commitments under the Minamata Convention, and these policies in combination, and evaluate deposition using a global atmospheric transport model. We find climate policy in China can provide mercury benefits when implemented with Minamata policy, achieving in the year 2030 approximately 5% additional reduction in mercury emissions and deposition in China when climate policy achieves a 5% reduction per year in carbon intensity (CO2 emissions 9.7 Gt in 2030). This corresponds to 63 Mg additional mercury emissions reductions in 2030 when implemented with Minamata Convention policy, compared to Minamata policy implemented alone. Climate policy provides emissions reductions in sectors not considered under the Minamata Convention, such as residential combustion. This changes the combination of sectors that contribute to emissions reductions.JRC.C.5-Air and Climat
Mercury Benefits of Climate Policy in China: Addressing the Paris Agreement and Minamata Convention Simultaneously
National commitments under the Paris Agreement on climate change interact with other global environmental objectives, such as those of the Minamata Convention on Mercury. We assess how mercury emissions and deposition reductions from national climate policy in China under the Paris Agreement could contribute to the country's commitments under the Minamata Convention. We examine emissions under climate policy scenarios developed using a computable general equilibrium model of China's economy, end-of-pipe control scenarios that meet China's commitments under the Minamata Convention, and these policies in combination, and evaluate deposition using a global atmospheric transport model. We find climate policy in China can provide mercury benefits when implemented with Minamata policy, achieving in the year 2030 approximately 5\% additional reduction in mercury emissions and deposition in China when climate policy achieves a 5% reduction per year in carbon intensity (CO2 emissions 9.7 Gt in 2030). This corresponds to 63 Mg additional mercury emissions reductions in 2030 when implemented with Minamata Convention policy, compared to Minamata policy implemented alone. Climate policy provides emissions reductions in sectors not considered under the Minamata Convention, such as residential combustion. This changes the combination of sectors that contribute to emissions reductions.
This data submission includes scripts to project China's 2012 mercury emissions from the Emissions Database for Global Atmospheric Research (EDGAR) and prepare them for input to the global chemical transport model, GEOS-Chem. It also includes scripts to plot projected emissions and plot deposition results (with required raw results from GEOS-Chem) for the figures included in the Environmental Science and Technology article
Recommended from our members
Harnessing the power within: engineering the microbiome for enhanced gynecologic health
Graphical abstractAbstractAlthough numerous studies have demonstrated the impact of microbiome manipulation on human health, research on the microbiome's influence on female health remains relatively limited despite substantial disease burden. In light of this, we present a selected review of clinical trials and preclinical studies targeting both the vaginal and gut microbiomes for the prevention or treatment of various gynecologic conditions. Specifically, we explore studies that leverage microbiota transplants, probiotics, prebiotics, diet modifications, and engineered microbial strains. A healthy vaginal microbiome for females of reproductive age consists of lactic acid-producing bacteria predominantly of the Lactobacillus genus, which serves as a protective barrier against pathogens and maintains a balanced ecosystem. The gut microbiota's production of short-chain fatty acids, metabolism of primary bile acids, and modulation of sex steroid levels have significant implications for the interplay between host and microbes throughout the body, ultimately impacting reproductive health. By harnessing interventions that modulate both the vaginal and gut microbiomes, it becomes possible to not only maintain homeostasis but also mitigate pathological conditions. While the field is still working toward making broad clinical recommendations, the current studies demonstrate that manipulating the microbiome holds great potential for addressing diverse gynecologic conditions.Lay summaryManipulating the microbiome has recently entered popular culture, with various diets thought to aid the microbes that live within us. These microbes live in different locations of our body and accordingly help us digest food, modulate our immune system, and influence reproductive health. The role of the microbes living in and influencing the female reproductive tract remains understudied despite known roles in common conditions such as vulvovaginal candidiasis (affecting 75% of females in their lifetime), bacterial vaginosis (25% of females in their lifetime), cervical HPV infection (80% of females in their lifetime), endometriosis (6-10% of females of reproductive age), and polycystic ovary syndrome (10-12% of females of reproductive age). Here, we review four different approaches used to manipulate the female reproductive tract and gastrointestinal system microbiomes: microbiota transplants, probiotics, prebiotics, and dietary interventions, and the use of engineered microbial strains. In doing so, we aim to stimulate discussion on new ways to understand and treat female reproductive health conditions